OA10998A - Use of benzopyranols to treat neurological disorders - Google Patents
Use of benzopyranols to treat neurological disorders Download PDFInfo
- Publication number
- OA10998A OA10998A OA9900060A OA9900060A OA10998A OA 10998 A OA10998 A OA 10998A OA 9900060 A OA9900060 A OA 9900060A OA 9900060 A OA9900060 A OA 9900060A OA 10998 A OA10998 A OA 10998A
- Authority
- OA
- OAPI
- Prior art keywords
- pain
- treatment
- acetyl
- dimethyl
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10998A true OA10998A (en) | 2003-03-04 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA9900060A OA10998A (en) | 1996-09-18 | 1999-03-18 | Use of benzopyranols to treat neurological disorders |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (tr) |
| JP (1) | JP2001500520A (tr) |
| KR (1) | KR20000036184A (tr) |
| CN (1) | CN1230885A (tr) |
| AP (1) | AP9901473A0 (tr) |
| AR (1) | AR008838A1 (tr) |
| AT (1) | ATE270102T1 (tr) |
| AU (1) | AU730465B2 (tr) |
| BG (1) | BG103252A (tr) |
| BR (1) | BR9712030A (tr) |
| CA (1) | CA2266681A1 (tr) |
| DE (1) | DE69729735T2 (tr) |
| DZ (1) | DZ2311A1 (tr) |
| EA (1) | EA199900306A1 (tr) |
| ES (1) | ES2223075T3 (tr) |
| GB (1) | GB9619492D0 (tr) |
| HU (1) | HUP9904638A3 (tr) |
| ID (2) | ID23175A (tr) |
| IL (1) | IL128786A0 (tr) |
| MA (1) | MA24321A1 (tr) |
| NO (1) | NO991292L (tr) |
| NZ (1) | NZ334271A (tr) |
| OA (1) | OA10998A (tr) |
| PE (1) | PE109898A1 (tr) |
| PL (1) | PL332313A1 (tr) |
| SK (1) | SK35199A3 (tr) |
| TR (1) | TR199900527T2 (tr) |
| UY (1) | UY24717A1 (tr) |
| WO (1) | WO1998011890A1 (tr) |
| ZA (1) | ZA978359B (tr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| MX2010013313A (es) * | 2008-06-05 | 2011-05-30 | Minster Res Ltd | Tratamientos novedosos. |
| EP2296646A2 (en) * | 2008-06-05 | 2011-03-23 | Minster Research Limited | Novel treatments |
| AU2010276537B2 (en) | 2009-07-27 | 2015-04-16 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| MX2012006353A (es) * | 2009-12-03 | 2012-06-27 | Proximagen Ltd | Tratamiento de enfermedades infecciosas. |
| CN102970991A (zh) * | 2009-12-03 | 2013-03-13 | 普罗克西梅根有限公司 | 异常性疼痛和痛觉增敏的治疗 |
| MX2012015096A (es) | 2010-07-02 | 2013-05-28 | Gilead Sciences Inc | Compuestos heterociclicos fusionados como moduladores del canal ion. |
| EP2707361B1 (en) | 2011-05-10 | 2017-08-23 | Gilead Sciences, Inc. | Fused heterocyclic compounds as sodium channel modulators |
| TWI622583B (zh) | 2011-07-01 | 2018-05-01 | 基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
| NO3175985T3 (tr) | 2011-07-01 | 2018-04-28 | ||
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
| DK0764157T3 (da) * | 1994-06-10 | 2002-04-22 | Smithkline Beecham Plc | Benzopyraner og deres anvendelse som terapeutiske midler |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/tr unknown
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 EP EP97909300A patent/EP0939630B1/en not_active Expired - Lifetime
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Application Discontinuation
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Application Discontinuation
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292L/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DZ2311A1 (fr) | 2002-12-28 |
| AP9901473A0 (en) | 1999-03-31 |
| EP0939630A1 (en) | 1999-09-08 |
| ZA978359B (en) | 1999-03-17 |
| ID19542A (id) | 1998-07-23 |
| CA2266681A1 (en) | 1998-03-26 |
| MA24321A1 (fr) | 1998-04-01 |
| NO991292D0 (no) | 1999-03-17 |
| SK35199A3 (en) | 2000-07-11 |
| DE69729735D1 (de) | 2004-08-05 |
| AU4704797A (en) | 1998-04-14 |
| JP2001500520A (ja) | 2001-01-16 |
| PE109898A1 (es) | 1999-03-21 |
| BG103252A (en) | 1999-09-30 |
| HUP9904638A2 (hu) | 2001-05-28 |
| CN1230885A (zh) | 1999-10-06 |
| PL332313A1 (en) | 1999-08-30 |
| IL128786A0 (en) | 2000-01-31 |
| ID23175A (id) | 2000-03-23 |
| KR20000036184A (ko) | 2000-06-26 |
| AU730465B2 (en) | 2001-03-08 |
| NO991292L (no) | 1999-03-17 |
| WO1998011890A1 (en) | 1998-03-26 |
| AR008838A1 (es) | 2000-02-23 |
| UY24717A1 (es) | 2001-08-27 |
| HUP9904638A3 (en) | 2001-08-28 |
| ATE270102T1 (de) | 2004-07-15 |
| GB9619492D0 (en) | 1996-10-30 |
| EA199900306A1 (ru) | 1999-08-26 |
| NZ334271A (en) | 2001-03-30 |
| BR9712030A (pt) | 1999-08-24 |
| DE69729735T2 (de) | 2005-07-14 |
| EP0939630B1 (en) | 2004-06-30 |
| TR199900527T2 (tr) | 1999-06-21 |
| ES2223075T3 (es) | 2005-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK169593B1 (da) | Farmaceutiske præparater med forbedret stabilitet samt fremgangsmåde til stabilisering af et ACE-inhibitor lægemiddel | |
| EP1343495B1 (en) | Methods of treating anxiety disorders | |
| OA10998A (en) | Use of benzopyranols to treat neurological disorders | |
| WO2000012073A1 (en) | Use of 5ht-6 antagonists | |
| MX2010013312A (es) | Tratamientos novedoos. | |
| CA2726878A1 (en) | Novel treatments | |
| AU607728B2 (en) | Hypertension treatment using k+ channel activator and ace inhibitor agents | |
| CA2335846A1 (en) | Substituted benzopyran derivatives and their use as anticonvulsants | |
| US6492415B2 (en) | Use of benzopyranols to treat neurological disorders | |
| CA1327163C (en) | Anxiolytically active piperazine derivatives | |
| TW448046B (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity | |
| EP1448181B1 (en) | Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes | |
| JPH0525167A (ja) | 緑内障の治療に有用な置換ベンゼン誘導体 | |
| KR0177894B1 (ko) | 항우울제 | |
| US5886021A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis | |
| KR20010021796A (ko) | 선택성 세로토닌 재흡수 억제제 (ｓｓｒｉ)를 사용하는심장 질환의 치료 및 예방법 | |
| CZ92999A3 (cs) | Farmaceutický prostředek pro léčbu a/nebo profylaxi neurologických poruch a použití sloučenin obsahujících fosfor k výrobě léčiva | |
| CN110407789B (zh) | 一种防治骨质疏松的药物及其制备方法 | |
| WO1998033500A1 (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting senescence-associated motor impairment | |
| WO1987003807A1 (en) | Oxazole derivatives and their use as anti-hyperglycaemic | |
| KR100194825B1 (ko) | 말초 순환 개선제 | |
| JPS63165317A (ja) | 製薬生成物 | |
| HUT72589A (en) | Benzopyron analogues for the treatment of anxiety, mania, depression or withdrawal symptoms | |
| MXPA00010343A (en) | Treatment of generalized anxiety disorder with paroxetine | |
| CA2328896A1 (en) | Treatment of generalized anxiety disorder with paroxetine |